Progyny 10-Q: Q3 Net Income $26.3M, $230.9M Buyback, CEO/Chairman 10b5-1 Plans
PGNY sits 90% above its 52-week low of $16.1.
Summary
Progyny's Q3 10-Q confirms net income of $26.3M ($0.32 diluted) on $341.3M revenue, with $230.9M of buybacks in nine months and new 10b5-1 plans covering up to 1.97M CEO shares and 1.3M Chairman shares.
Key Events · Earnings and Guidance · PGNY
-
Q3 Profit Nearly Doubles
Net income of $26.3M versus $13.9M a year ago, on revenue of $341.3M (+9%); diluted EPS $0.32 versus $0.15.
-
Margins Expand on Lower Stock Comp
Gross margin rose to 24.5% from 23.2% and G&A fell 9% to $30.5M, helped by stock-based compensation dropping to $21.1M from $32.2M.
-
Aggressive Buyback Shrinks Share Count
9,681,135 shares repurchased in nine months at an average $23.83 for $230.9M; $85.8M remains under the May 2026 program, and Q3 alone bought 2,980,798 shares at $27.73.
-
Large Insider Selling Programs Set
CEO Pete Anevski adopted a 10b5-1 plan for up to 1,970,286 shares and Executive Chairman David Schlanger for up to 1,300,000 shares, both running to October 31, 2027.
Analysis · PGNY · Industrial Applications And Services
The headline numbers were already out on November 4, but the 10-Q is where the quality of the quarter shows: net income nearly doubled to $26.3M from $13.9M, gross margin rose to 24.5% from 23.2%, and nine-month operating cash flow held at $153.0M even after $32.6M of cash taxes. The company is also shrinking its share count fast — 9.68M shares repurchased for $230.9M in nine months at an average $23.83, with $85.8M still authorized — which is what makes the per-share earnings growth outpace the 9% revenue growth. Against that, the filing formalizes large pre-set selling programs: the CEO can sell up to 1,970,286 shares and the Executive Chairman up to 1,300,000 through October 2027, so insider supply will be a persistent overhang even as the company buys back stock.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PGNY was trading at $30.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $16.10 to $33.07. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.